Sophisticated natural products as antibiotics
- PMID: 39085542
- DOI: 10.1038/s41586-024-07530-w
Sophisticated natural products as antibiotics
Abstract
In this Review, we explore natural product antibiotics that do more than simply inhibit an active site of an essential enzyme. We review these compounds to provide inspiration for the design of much-needed new antibacterial agents, and examine the complex mechanisms that have evolved to effectively target bacteria, including covalent binders, inhibitors of resistance, compounds that utilize self-promoted entry, those that evade resistance, prodrugs, target corrupters, inhibitors of 'undruggable' targets, compounds that form supramolecular complexes, and selective membrane-acting agents. These are exemplified by β-lactams that bind covalently to inhibit transpeptidases and β-lactamases, siderophore chimeras that hijack import mechanisms to smuggle antibiotics into the cell, compounds that are activated by bacterial enzymes to produce reactive molecules, and antibiotics such as aminoglycosides that corrupt, rather than merely inhibit, their targets. Some of these mechanisms are highly sophisticated, such as the preformed β-strands of darobactins that target the undruggable β-barrel chaperone BamA, or teixobactin, which binds to a precursor of peptidoglycan and then forms a supramolecular structure that damages the membrane, impeding the emergence of resistance. Many of the compounds exhibit more than one notable feature, such as resistance evasion and target corruption. Understanding the surprising complexity of the best antimicrobial compounds provides a roadmap for developing novel compounds to address the antimicrobial resistance crisis by mining for new natural products and inspiring us to design similarly sophisticated antibiotics.
© 2024. Springer Nature Limited.
Similar articles
-
Role of Natural Product in Modulation of Drug Transporters and New Delhi Metallo-β Lactamases.Curr Top Med Chem. 2019;19(10):874-885. doi: 10.2174/1871529X19666190415110724. Curr Top Med Chem. 2019. PMID: 30987566 Review.
-
[Mechanisms of resistance to beta-lactam antibiotics].Infection. 1993;21 Suppl 1:S4-9. doi: 10.1007/BF01710336. Infection. 1993. PMID: 8314292 Review. German.
-
Progress toward inhibitors of metallo-β-lactamases.Future Med Chem. 2017 May;9(7):673-691. doi: 10.4155/fmc-2017-0007. Epub 2017 May 15. Future Med Chem. 2017. PMID: 28504895 Review.
-
Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization.Microbiol Spectr. 2022 Oct 26;10(5):e0045022. doi: 10.1128/spectrum.00450-22. Epub 2022 Sep 7. Microbiol Spectr. 2022. PMID: 36069578 Free PMC article.
-
Antibacterial and β-Lactamase Inhibitory Activity of Monocyclic β-Lactams.Med Res Rev. 2018 Mar;38(2):426-503. doi: 10.1002/med.21443. Epub 2017 Aug 16. Med Res Rev. 2018. PMID: 28815732 Review.
Cited by
-
Deciphering the Intricate Interplay in the Framework of Antibiotic-Drug Interactions: A Narrative Review.Antibiotics (Basel). 2024 Oct 5;13(10):938. doi: 10.3390/antibiotics13100938. Antibiotics (Basel). 2024. PMID: 39452205 Free PMC article. Review.
References
-
- Lewis, K. The science of antibiotic discovery. Cell 181, 29–45 (2020). - PubMed
-
- Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318–327 (2018). - PubMed
-
- Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399, 629–655 (2022).
-
- Ramos-Castaneda, J. A. et al. Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections. J. Infect. 76, 438–448 (2018). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical